UPDATE : Wednesday, March 27, 2019
상단여백
‘Hair loss drug Propesia works well for Koreans in long term’
MSD Korea’s Propesia (ingredient: finasteride), which has been used as male...
by Kim Yun-mi  |  2019-02-18 16:38
라인
Hanmi’s RaboneD dominates osteoporosis therapy market
Hanmi Pharmaceutical’s RaboneD, an osteoporosis treatment in the selective ...
by Kim Yun-mi  |  2019-02-18 14:23
라인
Humedix posts record-high sales in Q4 sales
Humedix said Friday that its earnings turned around and has posted record-h...
by Lee Han-soo  |  2019-02-18 14:22
라인
‘Hospitals are culprit of fatal bullying of nurses’
The nursing community and their supporters gathered in Seoul to commemorate...
by Lee Min-ju  |  2019-02-18 14:22
라인
Ministry OKs Peptron’s P2 clinical trial of Parkinson’s disease treatment
Peptron said Monday that the Ministry of Food and Drug Safety has approved ...
by Lee Han-soo  |  2019-02-18 11:13
라인
Sillajen’s research selected as cover paper for international journal
Sillajen said Friday that the Clinical Cancer Research, an international jo...
by Lee Han-soo  |  2019-02-15 17:36
라인
Korean researchers find gene responsible for extremely rare disease
Researchers have discovered the gene responsible for sponastrime dysplasia,...
by Lee Han-soo  |  2019-02-15 16:40
라인
SK Biopharmaceuticals, Arvelle to develop, commercialize cenobamate in Europe
SK Biopharmaceuticals said Thursday that it has signed an exclusive licensi...
by Lee Han-soo  |  2019-02-15 15:36
라인
Acute myeloid leukemia treatment Rydapt approved as orphan drug
The regulatory agency approved Rydapt 25mg (ingredient: midostaurin), a tre...
by Lee Hye-seon  |  2019-02-15 15:36
라인
Fine dust has lag effects on people with respiratory illnesses: report
With a special law on reducing fine dust taking effect on Friday, a local s...
by Song Soo-youn  |  2019-02-15 15:35
라인
Sanofi Genzyme Korea launches rare blood disorder franchise
Sanofi Genzyme Korea, a subsidiary of Sanofi, said Thursday that it has lau...
by Lee Han-soo  |  2019-02-15 14:37
라인
GC starts P2 trials of hepatitis B treatment
GC said Thursday that it has administered the first dose of GC1102, a new r...
by Lee Han-soo  |  2019-02-15 14:36
라인
MSD leads rapidly growing antidiabetic DPP-4 inhibitors market
MSD took the No. 1 position in sales of antidiabetic dipeptidyl peptidase-4...
by Kim Yun-mi  |  2019-02-15 14:31
라인
Dong-A ST posts ₩567.2 billion in 2018 sales
Dong-A ST said Wednesday that it recorded the sales of 567.2 billion ($504....
by Lee Han-soo  |  2019-02-14 16:13
라인
Korea sets guideline for pediatric obesity treatment for 1st time in Asia
The Korean Society of Pediatric Gastroenterology, Hepatology, and Nutrition...
by Choi Gwang-seok  |  2019-02-14 15:35
라인
Direct-acting antivirals reduce death risk for hepatitis C patients: study
Direct-acting antivirals showed a clinical effect on chronic hepatitis C pa...
by Kim Yun-mi  |  2019-02-14 14:59
라인
Regulators fine Smith & Nephew for providing rebates
The Fair Trade Commission (FTC) said Thursday that it has imposed a 300 mil...
by Lee Han-soo  |  2019-02-14 14:34
라인
Theragen commercializes customized genetic analysis chip
Theragen Etex said Wednesday that it would start a big data-based gene insp...
by Lee Han-soo  |  2019-02-14 14:33
라인
Blood-thinning NOAC market expands 30% in 2018
The domestic market of non-vitamin K antagonist oral anticoagulants (NOAC) ...
by Kim Yun-mi  |  2019-02-14 12:12
라인
‘Innovative’ drugmakers to invest ₩1.7 trillion in developing new drugs
Forty-three out of the 47 government-designated innovative drugmakers will ...
by Lee Han-soo  |  2019-02-14 11:26
여백
여백
여백
Back to Top